fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » UTI Healthcare Fund

UTI Healthcare Fund - G

NAV  ₹142.904 ↑ 1.96  (1.39 %) as on 19 Jan 21

(Erstwhile UTI Pharma & Healthcare Fund)

Scheme Objective

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a CAGR return of 14.6% since its launch.  Ranked 40 in Sectoral category. .

Below is the key information for UTI Healthcare Fund

NAV as on 19 Jan 21₹142.904 ↑ 1.96  (1.39 %)
Net Assets (AUM) as on 30 Nov 2020 ₹610 Cr.
Launch Date28 Jun 1999
CategoryEquity - Sectoral
Rating
TypeOpen Ended Fund
RiskHigh
AMCUTI Asset Management Company Ltd
Alpha Ratio7.26
Expense Ratio2.59 %
Sharpe Ratio1.548
Information Ratio0.33
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 19 Jan 21

DurationReturns
1 Month 1.4%
3 Month 10.6%
6 Month 29.7%
1 Year 61.1%
3 Year 16.3%
5 Year 10%
10 Year
15 Year
Since launch 14.6%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2020
2019
2018
2017
2016
2015
2014
2013
2012

Growth of 10k Over Years

DateValue
31 Dec 15₹10,000
31 Dec 16₹9,029
31 Dec 17₹9,589
31 Dec 18₹8,867
31 Dec 19₹8,971
31 Dec 20₹15,014
UTI Healthcare Fund Growth 10k Chart

Asset Allocation

Asset ClassValue
Cash3.27%
Equity96.73%
UTI Healthcare Fund Asset Allocation

Sector Allocation

SectorValue
Health Care94.5%
Basic Materials2.22%
UTI Healthcare Fund Equity Allocation

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
Drug Manufacturers - Specialty & Generic10%₹67 Cr1,132,558
↓ -106,562
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 500124
Drug Manufacturers - Specialty & Generic9%₹58 Cr110,782
↓ -3,408
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA
Drug Manufacturers - Specialty & Generic9%₹58 Cr624,369
↑ 55,822
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
Drug Manufacturers - General8%₹54 Cr654,227
↑ 15,676
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
Drug Manufacturers - Specialty & Generic7%₹43 Cr111,549
↓ -13,534
Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | 540596
Drug Manufacturers - Specialty & Generic5%₹34 Cr578,554
↑ 88,828
Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 03 | 532321
Drug Manufacturers - Specialty & Generic5%₹32 Cr667,045
↓ -89,236
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Jan 20 | NH
Medical Care Facilities4%₹26 Cr580,716
↓ -34,154
Biocon Ltd (Healthcare)
Equity, Since 31 Oct 18 | 532523
Biotechnology4%₹24 Cr516,118
Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331
Drug Manufacturers - Specialty & Generic3%₹23 Cr137,818
↑ 8,595
1 - 10 of 27
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
V Srivatsa3 Mar 173.83 Yr.

Custodians

CompanyAddress
Bank of Nova Scotia12/13, Maker Chamber VI,220, Nariman Point
Citibank N.A. IndiaTrent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East),
Stock Holding Corporation of IndiaMittal Court, ‘B’ Wing,,Nariman Point

Registrar & Transfer Agent

KFin Technologies Private Limited
Address"KARVY HOUSE",46, Avenue 4, Street No.1,,Banjara Hills,
FAX91-40-23311968
Emailmailmanager@karvy.com

Administrator Companies

CompanyAddress
UTI Mutual FundUTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E)

Auditors

CompanyAddress
Haribhakti & Co. Chartered Accountants42, Free Press House,4th Floor,,215, Nariman Point,

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
UTI Healthcare Fund
Growth
₹142.904
↑ 1.96
29.66 %61.07 %16.31 %9.98 %
UTI Healthcare Fund
Normal Dividend, Payout
₹110.444
↑ 1.52
29.66 %61.07 %16.31 %9.98 %
UTI Healthcare Fund
Normal Dividend, Reinvestment
₹110.444
↑ 1.52
29.66 %61.07 %16.31 %9.98 %
Data as on 19 Jan 21

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.